title: Outcomes following transoral robotic surgery: supraglottic laryngectomy.
abstract: OBJECTIVE
  To describe a single center outcomes following transoral robotic surgery for supraglottic laryngectomy (TORS-SL).
  
  
  METHODS
  Prospective data collection.
  
  
  METHODS
  Patient records receiving TORS-SL for squamous cell carcinoma (SCCA) with at least 12 months follow-up fit inclusion for this study. Two patients with previous SCCA were excluded.
  
  
  RESULTS
  18 patients (14 male, 4 female) were included in the study, having a mean follow-up time of 28.1 months (SD = 12.1). All patients had negative margins confirmed on final pathology. Nine (50%) patients received postoperative chemoradiation therapy for advanced neck disease. No (0%) patients received tracheostomy or gastrostomy tubes. There were no (0%) local recurrences, and three (16.7%) regional recurrences. Five (27.8%) patients experienced temporary postoperative complications. Overall 2-year outcomes reached 83%, 100%, and 89% for locoregional control, disease-specific survival, and overall survival respectively.
  
  
  CONCLUSIONS
  Initial outcomes for TORS-SL are encouraging and are comparable to previously described treatment modalities. Larger studies are encouraged.
authors.affiliation: Department of Head and Neck Surgery, David Geffen School of Medicine at UCLA, Los Angeles, California 90095, USA. Amendelsohn@mednet.ucla.edu
authors.forename: Abie H
authors.initials: AH
authors.lastname: Mendelsohn
authors.forename: Marc
authors.initials: M
authors.lastname: Remacle
authors.forename: Sebastien
authors.initials: S
authors.lastname: Van Der Vorst
authors.forename: Vincent
authors.initials: V
authors.lastname: Bachy
authors.forename: Georges
authors.initials: G
authors.lastname: Lawson
mesh_terms: D002294:Carcinoma, Squamous Cell / Q000401:mortality / Q000601:surgery*; D005260:Female; D005500:Follow-Up Studies; D006258:Head and Neck Neoplasms / Q000401:mortality / Q000601:surgery*; D006801:Humans; D007822:Laryngeal Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D007825:Laryngectomy / Q000009:adverse effects / Q000379:methods*; D007830:Larynx / Q000473:pathology / Q000601:surgery*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000401:mortality / Q000601:surgery; D011183:Postoperative Complications; D011379:Prognosis; D011446:Prospective Studies; D012371:Robotics / Q000379:methods*; D000077195:Squamous Cell Carcinoma of Head and Neck; D016019:Survival Analysis; D016896:Treatment Outcome